Wear it pink this October At work. At school. At home. Wherever you do it, wear pink and raise money to fund life-changing research and support
Home About us Media Breast Cancer Now media statements 166 results We respond to NICE guidance to not recommend Enhertu for HER2-low secondary breast cancer remaining unchanged 19 Nov 2024 1 min read We respond to the National Cancer Medicines Advisory Group in Scotland supporting use of anastrozole, tamoxifen and raloxifene to reduce risk of breast cancer 24 Oct 2024 1 min read We respond to new research that suggests women who use a contraceptive coil may have a slightly higher risk of developing breast cancer 17 Oct 2024 1 min read We respond to news that a blood test could detect 12 most common cancers before symptoms develop 08 Oct 2024 2 min read We respond to NICE provisional decision to not recommend elacestrant in England 01 Oct 2024 1 min read We respond to NICE Board decision to not make changes to severity modifier 25 Sept 2024 2 min read Our response to new analysis from Cancer Research UK revealing more than 300,000 cancer patients face delays over the next five years 20 Sept 2024 1 min read We respond to the National Audit of Metastatic Breast Cancer State of the Nation Report 2024 12 Sept 2024 1 min read We respond to Elle Macpherson sharing her breast cancer diagnosis 7 years ago 03 Sept 2024 1 min read Breast Cancer Now respond to devastating NICE decision to not recommend life-extending breast cancer drug Enhertu in England 29 Jul 2024 2 min read We respond to Royal College of Radiologists' 2023 Clinical Radiology and Oncology Census Reports 13 Jun 2024 1 min read We respond to research that has shown breast cancer rates increasing amongst younger people 03 Jun 2024 1 min read Previous 1 2 ... 14 Next
We respond to NICE guidance to not recommend Enhertu for HER2-low secondary breast cancer remaining unchanged 19 Nov 2024 1 min read
We respond to the National Cancer Medicines Advisory Group in Scotland supporting use of anastrozole, tamoxifen and raloxifene to reduce risk of breast cancer 24 Oct 2024 1 min read
We respond to new research that suggests women who use a contraceptive coil may have a slightly higher risk of developing breast cancer 17 Oct 2024 1 min read
We respond to news that a blood test could detect 12 most common cancers before symptoms develop 08 Oct 2024 2 min read
We respond to NICE provisional decision to not recommend elacestrant in England 01 Oct 2024 1 min read
Our response to new analysis from Cancer Research UK revealing more than 300,000 cancer patients face delays over the next five years 20 Sept 2024 1 min read
We respond to the National Audit of Metastatic Breast Cancer State of the Nation Report 2024 12 Sept 2024 1 min read
We respond to Elle Macpherson sharing her breast cancer diagnosis 7 years ago 03 Sept 2024 1 min read
Breast Cancer Now respond to devastating NICE decision to not recommend life-extending breast cancer drug Enhertu in England 29 Jul 2024 2 min read
We respond to Royal College of Radiologists' 2023 Clinical Radiology and Oncology Census Reports 13 Jun 2024 1 min read
We respond to research that has shown breast cancer rates increasing amongst younger people 03 Jun 2024 1 min read
